Call Options

13 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$1.33 - $2.51 $25,270 - $47,689
19,000 New
19,000 $47,000
Q4 2022

Feb 14, 2023

BUY
$1.13 - $10.8 $78,082 - $746,280
69,100 Added 193.56%
104,800 $146,000
Q3 2022

Nov 14, 2022

BUY
$3.0 - $5.49 $39,600 - $72,468
13,200 Added 58.67%
35,700 $113,000
Q2 2022

Aug 15, 2022

SELL
$3.13 - $12.25 $222,543 - $870,975
-71,100 Reduced 75.96%
22,500 $78,000
Q1 2022

May 16, 2022

BUY
$9.54 - $14.26 $641,088 - $958,272
67,200 Added 254.55%
93,600 $1.06 Million
Q4 2021

Feb 14, 2022

BUY
$7.34 - $10.25 $118,908 - $166,050
16,200 Added 158.82%
26,400 $253,000
Q2 2021

Aug 11, 2021

SELL
$11.76 - $16.85 $255,192 - $365,645
-21,700 Reduced 68.03%
10,200 $125,000
Q1 2021

May 17, 2021

SELL
$14.21 - $25.3 $976,227 - $1.74 Million
-68,700 Reduced 68.29%
31,900 $508,000
Q4 2020

Feb 16, 2021

BUY
$14.8 - $20.37 $401,080 - $552,027
27,100 Added 36.87%
100,600 $1.54 Million
Q3 2020

Nov 16, 2020

BUY
$11.74 - $22.0 $207,798 - $389,400
17,700 Added 31.72%
73,500 $1.37 Million
Q1 2020

May 15, 2020

SELL
$4.22 - $9.8 $228,724 - $531,160
-54,200 Reduced 49.27%
55,800 $333,000
Q3 2019

Nov 14, 2019

SELL
$10.0 - $17.01 $7,000 - $11,907
-700 Reduced 0.63%
110,000 $1.11 Million
Q2 2019

Nov 14, 2019

BUY
$7.88 - $33.2 $872,316 - $3.68 Million
110,700 New
110,700 $1.27 Million

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $33M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.